Approximately 1.5 million women and girls in the United States have epilepsy, of which nearly 500,000 are women of childbearing age. Treating women with epilepsy, especially women of childbearing age, presents significant challenges to physicians. Epilog.us [http://www.epilog.us], Upsher-Smith Laboratories, Inc’s [http://www.upsher-smith.com] epilepsy-focused educational website, discusses these challenges and provides professional insight by some of the epilepsy community’s most respected physicians including Dr. Cynthia Harden, Chief of the Comprehensive Epilepsy Care Center, North Shore University Hospital and Long Island Jewish Medical Center, and Dr. Christopher Skidmore, Director of Neurology Residency/Assistant Professor of Neurology, at Jefferson Medical College of Thomas Jefferson University.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59306-upsher-smith-epilog-website-challenges-in-managing-women-with-epilepsy
Daily Glow (www.dailyglow.com), the leading online healthy beauty authority, announced the winners of its Daily Glow Awards honoring products across the beauty spectrum. After in–depth research, testing and analysis of thousands of products, a judging panel of medical and beauty experts named 100 products for their outstanding achievement in innovation, recognizing the most inventive, state–of–the–art and truly original products. The Daily Glow 2012 Award winners were announced today in an expansive editorial feature on DailyGlow.com/Awards. (Award winners were previewed at a private ceremony held at The Standard Hotel in New York City last night.)
To view Multimedia News Release, go to http://www.multivu.com/mnr/54945-everyday-health-daily-glow
Every 40 seconds a stroke occurs in the United States, according to the American Heart Association/American Stroke Association. To raise awareness about F.A.S.T. — an acronym to recognize and respond to the sudden warning signs of stroke, the American Heart Association/American Stroke Association and Ad Council are unveiling a new, national multimedia public service advertisement (PSA) campaign. F.A.S.T. is designed to help bystanders spot a stroke fast because the quicker a stroke victim receives medical attention, the greater his or her chances of survival and a better recovery. To view Multimedia News Release, go to http://www.multivu.com/mnr/58828-ad-council-american-stroke-association-stroke-awareness-f-a-s-t
The Gout & Uric Acid Education Society (GUAES) has added six new educational videos for patients and medical professionals to its library of popular educational videos on gout, highlighting the society’s most important takeaways from the recently released American College of Rheumatology (ACR) Guidelines on Gout Diagnosis and Treatment. Available under the patient and medical professional portals on www.GoutEducation.org, respectively, the latest videos emphasize the need for continuous communication between gout patients and their doctors about their unique treatment plan, to help prevent gout flares and long-term complications from this poorly understood form of inflammatory arthritis.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60699-gout-uric-acid-education-society-guaes-new-videos-on-acr-guidelines
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
1st question: How can you make oral s*x less painful in your jaw?
The pain in your jaw when perform blowj*b could be caused by a TMJ disorder and you may need to seek professional help. Then you need to open up and elaborate the problem to your doctor. But of course, you don’t want to get in trouble by sucking your own doctor’s c*ck or even involve in a three-way situation by inviting in a medical staff, like a nurse perhaps.
Also you might want to change the position on the way you blow your partner’s organ. You may also want to relax when you are actually doing it.
2nd question: Does size really matter?
Yes. Size really matters. Some other things matter so much more than a few others out there. But what’s more important is that you should utilize what you have in a professional way. And you should always work things out to get them connected. You might also want to consider that not everybody fits anybody else.
Columbus businessman Scott Ressmeyer and 11 friends have started their 2013 Scott’s Ride for Miracles, a 21-day, 9,000-mile, 48-state motorcycle trek to raise awareness and money to benefit Children’s Miracle Network at The Medical Center in Columbus, Ga. The Miracle Send-Off Ceremony was held at 11:30 a.m. Friday morning, then at noon, the riders revved up their Harley engines and roared out of The Medical Center.
To view Multimedia News Release, go to http://www.multivu.com/players/English/61569-columbus-regional-healthcare-system-scotts-ride-for-miracles
The number of gout patients is rising, with an estimated 8.3 million American adults diagnosed with gout—but only 10 percent of them are being properly treated, according to the Gout & Uric Acid Education Society. To heighten awareness and knowledge about gout and to lead to earlier diagnosis and treatment, the society has released two new comprehensive kits to educate patients and provide consistent information for medical professionals. The release of the Take a Stand on Gout Patient Education Kit and Medical Professional Information Kit coincides with Gout Awareness Day, an annual commemoration on May 22 to call attention to the growing incidence of gout and to enhance knowledge so as to improve patient outcomes. Both kits provide new, substantial information about gout from specialists, who treat gout patients every day.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61805-gout-uric-acid-education-society-take-a-stand-on-gout-new-information-kits
Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
Eisai Inc. announced today that BELVIQ (pronounced BEL-VEEK) will be available to eligible patients by prescription in the United States beginning June 11.
BELVIQ was approved by the U.S. Food and Drug Administration on June 27, 2012 to be used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults who have a body mass index (BMI) of 30 kg/m² or greater (obese), or BMI of 27 kg/m² or greater (overweight) with at least one weight-related medical condition such as high blood pressure, high cholesterol, or type 2 diabetes. It is not known if BELVIQ is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products, nor is it known if BELVIQ changes your risk of heart problems or stroke, or of death due to heart problems or stroke.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60316-eisai-belviq-civ-chronic-weight-management-tablets-for-overweight-adults
